immunogen
compon
isol
illinoi
propag
young
swine
miller
cell
cultureadapt
strain
porcin
transmiss
gastroenter
tge
viru
viral
subunit
releas
virion
sonic
separ
intact
viru
viral
compon
isopycn
centrifug
buoyant
densiti
sucros
gml
purif
consist
gel
filtrat
sephadex
process
immunogen
molecular
weight
approxim
last
compon
elut
group
ten
young
wean
swine
inocul
intramuscularli
two
three
dose
viral
subunit
protect
challeng
virul
tge
viru
probabl
induct
secretori
iga
immunogen
also
induc
humor
immun
respons
variabl
magnitud
titer
rang
anim
antibodi
believ
directli
relat
protect
infect
howev
easili
identifi
serolog
procedur
may
serv
conveni
indic
respons
tge
viral
immunogen
porcin
transmiss
gastroenter
viral
subunit
vaccin
tge
transmiss
gastroenter
tge
viru
pathogen
caus
enter
diseas
swine
age
diseas
especi
sever
newborn
pig
epizoot
mortal
rate
among
anim
wk
age
approach
addit
enzoot
form
tge
exist
persist
problem
particularli
among
young
wean
swine
nurseri
sinc
exist
efficaci
treatment
progress
diseas
limit
primarili
immun
respons
led
effort
mani
laboratori
develop
vaccin
andor
strategi
administr
thu
far
effort
unit
state
countri
remain
without
success
instanc
intramuscular
im
inocul
intact
tge
virus
result
product
circul
antibodi
sometim
high
titer
less
success
achiev
induc
protect
antibodi
believ
secretori
iga
ingest
live
viru
infect
intestin
tract
stimul
submucos
immunocompet
cell
consid
essenti
trigger
secret
iga
antibodi
virul
viru
rel
effici
induc
resist
subsequ
infect
resist
challeng
oral
vaccin
attenu
strain
tge
viru
caus
limit
damag
epitheli
cell
intestin
villi
prove
highli
variabl
addit
problem
associ
use
live
virus
vaccin
gener
may
condit
revert
virul
clinic
diseas
may
result
reason
attent
recent
year
direct
toward
use
viral
subunit
immunogen
paper
describ
subunit
compon
isol
virul
strain
tge
viru
shown
laboratori
experi
effect
safe
immunogen
induct
protect
swine
challeng
pathogen
pig
duroc
yorkshir
breed
obtain
tgefre
herd
babi
pig
propag
tge
viru
remov
sow
ingest
colostrum
infect
viru
h
birth
fed
spflac
porcin
milk
replac
borden
chemic
pet
product
norfolk
va
usa
dispos
paper
bowl
hous
individu
dispos
box
isol
unit
maintain
constant
humid
evalu
immunogen
viral
subunit
anim
weigh
approxim
lb
start
experi
hous
group
isol
unit
fed
nonmed
grower
ration
neonat
pig
inocul
per
os
median
neonat
pig
infect
dose
tge
viru
illinoi
isol
anim
kill
clinic
sign
tge
develop
signifi
pathogen
replic
jejunum
collect
harvest
viru
presenc
tge
confirm
fluoresc
antibodi
fa
stain
viral
antigen
intestin
homogen
eagl
minimum
essenti
medium
mem
contain
lactalbumin
hydrolys
lah
porcin
serum
make
gut
slurri
macromolecular
cellular
debri
remov
centrifug
x
g
min
refriger
centrifug
supernat
fluid
collect
isol
tge
viru
store
cell
cultureadapt
miller
number
isol
tge
viru
propag
monolay
swine
test
st
cell
roller
cultur
eagl
mem
contain
lah
meqml
kanamycin
nutrient
medium
cultur
cm
bottl
day
age
inocul
plaqueform
unit
viru
incub
humid
atmospher
day
viru
harvest
entir
content
roller
bottl
cell
layer
cultur
medium
frozen
dri
icealcohol
bath
thaw
three
time
releas
viru
cell
cellular
debri
remov
centrifug
x
g
min
supernat
fluid
contain
viru
store
procedur
use
prepar
immunogen
vivo
propag
illinoi
isol
vitro
replic
miller
number
isol
tge
viru
precipit
tge
viru
occur
follow
addit
polyethylen
glycol
peg
sodium
chlorid
mixtur
held
h
precipit
complet
centrifug
x
g
min
pellet
dispers
eagl
mem
volum
origin
layer
discontinu
sucros
gradient
sucros
trisedta
buffer
salin
ph
ratezon
centrifug
carri
x
g
h
sinc
buoyant
densiti
dehydr
tge
viru
associ
peg
gml
viru
sediment
sucros
interfac
materi
posit
collect
sonic
bioson
iv
sonic
oscil
bronwil
vmr
scientif
san
francisco
ca
usa
low
power
dialyz
trisedta
buffer
salin
ph
remov
sucros
fraction
isopycn
centrifug
continu
sucros
densiti
gradient
sucros
trisedtabuff
salin
ph
h
x
g
viru
freed
peg
sonic
buoyant
densiti
characterist
coronavirus
gml
immunogen
buoyant
densiti
gml
band
buoyant
densiti
gml
fraction
upward
flow
gel
filtrat
sephadex
pharmacia
fine
chemic
piscataway
ny
usa
flow
rate
mlh
fraction
collect
ultrarac
model
fraction
collector
lkb
instrument
inc
rockvil
md
usa
two
compon
evid
absorpt
wave
length
lam
immunogen
viral
subunit
molecular
weight
approxim
thu
last
fraction
elut
approxim
molecular
weight
subunit
immunogen
determin
electrophoresi
polyacrylamid
gel
denatur
condit
optim
medium
gel
filtrat
could
select
techniqu
use
determin
bishop
roy
gel
consist
wv
acrylamid
crosslinkag
contain
urea
wv
sodium
dodecyl
sulfat
prepar
phosphat
buffer
ph
phosphat
buffer
contain
urea
deterg
also
use
electrophoret
chamber
bromophenol
blue
incorpor
sampl
track
dye
electrophoresi
immunogen
solut
contain
seri
standard
protein
known
molecular
weight
sdspage
standardslow
molecular
weight
biorad
laboratori
richmond
ca
usa
perform
matub
h
bromophenol
blue
dye
reach
bottom
tube
protein
fix
stain
h
coomassi
brilliant
blue
eastman
kodak
rochest
ny
usa
prepar
acet
acid
gel
destain
mixtur
ethanol
acet
acid
distil
water
basi
mobil
rel
standard
molecular
weight
immunogen
calcul
approxim
tge
viral
subunit
immunogen
emulsifi
freund
complet
incomplet
adjuv
suspend
aluminum
hydroxid
indic
text
anim
receiv
mg
immunogen
lml
dose
im
rear
leg
antibodi
tge
assay
plaqu
reductionviru
neutral
procedur
cell
cultur
antibodi
titer
calcul
accord
reed
muench
formula
two
group
pig
immun
group
consist
tgeseroneg
pig
receiv
primari
inject
antigen
complet
freund
adjuv
follow
second
inject
incomplet
adjuv
day
later
four
anim
challeng
sixtieth
day
primari
immun
sera
collect
monitor
humor
immun
respons
four
pig
group
challeng
per
os
x
virul
illinoi
isol
tge
viru
sixtieth
day
remain
two
pig
given
third
dose
antigen
day
challeng
day
later
control
group
pig
receiv
inject
adjuv
group
ii
consist
pig
receiv
mg
immunogen
aluminum
hydroxid
second
inocul
given
day
later
anim
challeng
per
os
day
four
control
anim
receiv
salinealuminum
hydroxid
inoculum
swine
observ
close
clinic
sign
tge
attempt
made
isol
viru
fece
rectal
swab
use
st
cell
cultur
propag
viru
specimen
rectal
swab
fece
microscop
slide
also
stain
tgeviru
specif
fluoresc
antibodi
tgefa
effort
detect
presenc
viru
anim
becam
ill
kill
specimen
collect
jejunum
stain
tgefa
viru
isol
order
confirm
diagnosi
diseas
result
summar
tabl
tge
viru
delay
second
inocul
vaccin
low
titer
circul
antibodi
observ
wherea
specif
antibodi
evid
follow
singl
inocul
compon
deriv
highli
virul
illinoi
isol
tabl
high
titer
antibodi
occur
third
inocul
immunogen
prepar
illinoi
tge
viru
aluminum
hydroxid
tabl
freund
adjuv
tabl
effect
serv
promot
immun
respons
subunit
immunogen
tissu
reaction
observ
site
inocul
swine
receiv
immunogen
aluminum
hydroxid
granuloma
characterist
adjuv
observ
immunogen
given
freund
adjuv
control
pig
hous
anim
receiv
immunogen
seroconvert
prior
challeng
virul
tge
viru
clinic
sign
tge
observ
challeng
pig
receiv
either
miller
illinoi
tge
viral
subunit
viru
isol
fecal
specimen
obtain
unvaccin
control
swine
howev
develop
clinic
sign
tge
diarrhea
consist
indic
infect
one
pig
becam
sever
ill
die
sixth
day
postchalleng
fecal
sampl
obtain
sick
control
anim
contain
viru
stain
tgefa
also
pathogen
found
epitheli
cell
jejunum
pig
die
viru
isol
cell
cultur
stain
tgefa
sever
villou
atrophi
evid
six
pig
given
mg
tge
viral
subunit
immunogen
oral
dose
immunogen
anim
prepar
illinoi
strain
tge
viru
anim
sourc
miller
number
isol
pig
held
group
isol
unit
day
time
observ
close
clinic
sign
tge
attempt
made
isol
tge
viru
st
cell
cultur
fecal
specimen
rectal
swab
also
prepar
rectal
swab
fece
microscop
slide
stain
tgefa
conjug
identifi
pathogen
two
addit
pig
receiv
immunogen
hous
contact
none
pig
receiv
tge
viral
subunit
oral
develop
sign
diseas
pig
contact
becom
ill
viru
isol
fecal
specimen
evid
prepar
contain
virul
materi
mani
prepar
tge
viru
use
experiment
effort
develop
good
vaccin
control
diseas
product
made
avail
commerci
matter
conveni
im
rout
gener
chosen
administr
antigen
mani
case
success
achiev
humor
immun
respons
almost
uniformli
failur
respons
provid
satisfactori
protect
bohl
saif
saif
et
al
propos
problem
develop
protect
infect
associ
class
immunoglobulin
product
stimul
infect
intestin
tract
result
predominantli
secret
oflga
im
inocul
viru
result
synthesi
igg
iga
produc
local
neutral
tge
viru
lumen
small
intestin
littl
igg
releas
site
infect
furthermor
secretori
iga
rel
stabl
environ
digest
tract
igg
least
one
commerci
avail
vaccin
consist
attenu
viru
given
oral
im
pig
order
increas
efficaci
degre
protect
afford
disappoint
probabl
low
level
infect
gut
occur
inadequ
stimul
protect
immun
respons
also
inconveni
multidos
multirout
disadvantag
vaccin
howev
even
seriou
problem
live
vaccin
exist
theoret
danger
highli
suscept
anim
anim
may
infect
either
accid
time
immun
viru
contamin
environ
later
result
revers
attenu
viru
virul
pathogen
passag
host
speci
none
vaccin
feder
licens
unit
state
approv
use
newborn
suckl
pig
strain
tge
viru
develop
wood
tropism
crypt
cell
small
intestin
rather
villou
epitheli
cell
consequ
atrophi
villi
occur
follow
infect
clinic
sign
tge
observ
propos
isol
may
basi
vaccin
sinc
crypt
cell
matur
absorpt
villou
epitheli
cell
howev
one
must
give
care
consider
advis
introduc
new
viru
swine
herd
mani
viral
system
attent
direct
toward
develop
subunit
immun
agent
subunit
immunogen
produc
either
disrupt
fraction
virion
interrupt
sequenc
viral
replic
point
essenti
antigen
synthes
assembl
intact
virul
virion
occur
subunit
use
antigen
offer
advantag
complet
safe
nucleic
acid
essenti
replic
viru
elimin
toxic
factor
remov
also
select
compon
made
order
induc
antibodi
limit
specif
suitabl
activ
experiment
subunit
vaccin
consist
surfac
compon
frequent
glycoprotein
involv
attach
pathogen
host
cell
prior
invas
immun
reaction
direct
antigen
may
prevent
diseas
protect
primari
infect
may
produc
potenti
patholog
consequ
associ
antigenantibodi
interact
subunit
tge
viru
isol
laboratori
induc
protect
immun
respons
vaccin
pig
compon
discov
serendipit
byproduct
protocol
use
purif
viru
final
isopycn
centrifug
procedur
use
band
protein
buoyant
densiti
gml
alway
observ
sucros
gradient
attempt
identifi
compon
found
absorb
neutral
activ
hyperimmun
serum
unpubl
observ
therefor
fraction
inocul
rabbit
pig
hope
would
induc
product
highli
specif
antibodi
use
fluoresceinconjug
util
diagnost
procedur
secondarili
found
also
provid
protect
pig
challeng
virul
tge
viru
evalu
efficaci
vaccin
follow
describ
paper
efficaci
iminocul
subunit
vaccin
contrast
failur
intact
viru
administ
rout
provid
protect
tge
viru
readili
explain
possibl
rel
size
two
factor
signific
effect
upon
metabol
reaction
type
cell
site
involv
process
antigen
smaller
subunit
might
rapidli
dissemin
throughout
bodi
process
mani
site
includ
liver
stimul
immunocyt
variou
locat
thu
induc
class
antibodi
larger
virion
degrad
primarili
region
lymph
node
spleen
involv
phagocyt
cell
may
greater
import
igg
predomin
class
antibodi
produc
base
serolog
analys
circul
antibodi
produc
respons
tge
viral
subunit
amount
antibodi
detect
highli
variabl
anim
anim
rang
titer
pig
number
titer
pig
number
sinc
swine
lowest
titer
resist
tge
highest
titer
humor
antibodi
may
incident
protect
clinic
diseas
may
nonetheless
serv
conveni
indic
anim
respons
immunogen
believ
protect
antibodi
produc
could
measur
secretori
iga
releas
lumen
intestin
unpublish
preliminari
experi
limit
number
pig
indic
fluid
remov
lumen
intestin
immun
swine
contain
antibodi
sensit
molecular
size
larger
igg
critic
identif
immunoglobulin
secretori
iga
must
howev
await
determin
presenc
achain
secretori
piec
subject
research
tge
viru
rel
labil
physic
appear
electron
microscopi
alter
handl
viru
nativ
form
probabl
spheric
entiti
characterist
appear
pleomorph
coronaviru
surround
close
space
peplom
appear
halo
peplom
readili
lost
surfac
procedur
involv
prepar
microscop
examin
subunit
immunogen
believ
surfac
compon
virion
like
associ
peplom
readili
lost
probabl
glycoprotein
associ
attach
virion
host
cell
initi
step
infect
immun
reaction
direct
compon
provid
protect
prevent
initi
infect
intestin
villi
exact
natur
viral
subunit
immunogen
subject
continu
research
